Stock Price Quote

AAYUSH FOOD & HERBS LTD.

NSE : NABSE : 539528ISIN CODE : INE430R01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE223.954.35 (+1.98 %)
PREV CLOSE ( ) 219.60
OPEN PRICE ( ) 223.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2840
TODAY'S LOW / HIGH ( )223.95 223.95
52 WK LOW / HIGH ( ) 19223.95
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-06 1984
Management Info
Naveena kumar Kunjaru - Chairman Naveena kumar Kunjaru - Managing Director
Registered Office

Address 55, 2nd Floor, Lane 2,Westend Marg, Saidullajab,Near Saket ,metro Station,
New Delhi,
Delhi-110030

Phone 011 41009092

Email aayushfoodherbs06@gmail.com

Website www.aayush.health.com

Registrars Details
Beetal Financial & Computer Services (P) Ltd
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi
Listing : BSE, Delhi, MCX, MSE

NEWS

26Mar Change in Name of the Company
Inter alia, to consider and approve change the name of the company, shif..
26Mar Change of Registered Office
Inter alia, to consider and approve change the name of the company, shif..
23Nov Aayush Food and Herbs informs about di
Aayush Food and Herbs has informed that the exchange has received the di..
06Nov Aayush Food and Herbs informs about ne
In compliance with Regulation 47 of SEBI (Listing Obligations and Disclo..
28Oct Aayush Food and Herbs informs about di
Aayush Food and Herbs has informed that it enclosed the disclosure under..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit0.31-3.43000000000002
Gross Profit 0.31 -3.46000000000002
Operating Profit 0.31-2.53000000000002
Net Sales 81.02

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

NON-INSTITUTION 100%
PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Aayush Food & Herbs Ltd.

Aayush Food & Herbs Ltd. was incorporated in the year 1984. Its today's share price is 223.95. Its current market capitalisation stands at Rs 72.67 Cr. In the latest quarter, company has reported Gross Sales of Rs. 81.02 Cr and Total Income of Rs.86.49 Cr. The company's management includes Lalitkumar Anande, Gavadu Patil, Urmi Haresh Shah, Vishakha Umesh Jadhav, Naveena kumar Kunjaru, Naveena kumar Kunjaru, Pallavi Mittal.

It is listed on the BSE with a BSE Code of 539528 , NSE with an NSE Symbol of and ISIN of INE430R01015. It's Registered office is at 55, 2nd Floor, Lane 2,Westend Marg, Saidullajab,Near Saket ,metro StationNew Delhi-110030, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are GAMS & Associates LLP, Rajesh Lakshman & Associates, Rajesh Laxmi & Associates, SRDP & Co, Sudhir Agarwal & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.